Circulating Levels of MicroRNAs in Hypertrophic Cardiomyopathy: The Relationship With Left Ventricular Hypertrophy, Left Atrial Dilatation and Ventricular Depolarisation-Repolarisation Parameters.

Sonsoz M. R., Yilmaz M., Cevik E., Orta H., Bilge A. K., Elitok A., ...Daha Fazla

Heart, lung & circulation, cilt.31, ss.199-206, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1016/j.hlc.2021.04.019
  • Dergi Adı: Heart, lung & circulation
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.199-206
  • Anahtar Kelimeler: Echocardiography, Electrocardiography, Hypertrophic cardiomyopathy, MicroRNA, AMERICAN SOCIETY, MYOCARDIAL-INFARCTION, EUROPEAN ASSOCIATION, ECHOCARDIOGRAPHY, RECOMMENDATIONS, HEART, QUANTIFICATION, DIAGNOSIS, BIOMARKER, UPDATE
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background MicroRNAs are small, endogenous, non-coding RNAs that regulate the expression of many genes. It has recently been shown that circulating microRNAs may be biomarkers of hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy (HCM).